Status:
COMPLETED
Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Staten Island University Hospital
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
The investigators are trying to find out if Clopidogrel (Plavix) is as effective in hemodialysis patients as in patients not hemodialysed.
Detailed Description
Cardiovascular disease is very frequent in hemodialysis patients. Lot of hemodialysis patients are on Clopidogrel (plavix). Their is some evidence that clopidogrel is not effective in hemodialysis as ...
Eligibility Criteria
Inclusion
- All patients on hemodialysis taking Plavix
Exclusion
- known to have bleeding disorder
- Severely anemic with hemoglobin level (Hb) \< 10g/dl
- Low Platelets \< 10000
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01865890
Start Date
June 1 2010
End Date
April 1 2011
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Staten Island University Hospital
Staten Island, New York, United States, 10305